A printing inconsistency in the dose on one side of the outer packaging was found (15 mg stated incorrectly, it should be 30 mg). Potential effects: improper dosing, lack of treatment efficacy or adverse effects.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch PK181057. Patients should check the batch number of their medicine and, if it matches, return the package to the pharmacy; in case of doubts or any symptoms, contact ...
The Chief Pharmaceutical Inspector withdrew batch PK181057 of Apra-swift from the market throughout the country, granted the decision immediate enforceability, and obliged the marketing authorisation ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related